Canadian Manufacturing

SeaFort Capital announces investment in The Medicus Group

by CM Staff   

Financing Manufacturing Operations Risk & Compliance Sales & Marketing Small Business Electronics Infrastructure electronics financing Manufacturing medical manufacturing sales small business


The Company operates 19 clinics and employs more than 250 staff, including 145 orthotists, prosthetics, technicians, and other healthcare professionals.

HALIFAX — SeaFort Capital announces that it has made a majority investment in The Medicus Group, which represents Mable Health Inc.’s inaugural investment in the orthotics, prosthetics, and mobility aids industry. Headquartered in Montreal, Quebec, Médicus is a manufacturer of orthotics, prosthetics and mobility aid devices. The Company operates 19 clinics and employs more than 250 staff, including 145 orthotists, prosthetics, technicians, and other healthcare professionals.

Médicus’ General Manager, Michel Lanctôt, will now serve as the President of Mable Health and Médicus and will oversee Mable Health’s rollout of a national platform. Mr. Lanctôt commented, “We are very excited to be partnered with SeaFort Capital and to support the growth of the Mable Health business. We have a successful track record of operating an industry leading business which we are excited to leverage in expanding Mable Health across Canada.”

Rob Normandeau, SeaFort’s Managing Partner and President, commented, “This is SeaFort’s second investment in SeaFort Capital Fund II and SeaFort’s first investment in the healthcare sector. We have put a strong team in place to allow us to execute on a national buy-and-build strategy in the orthotics and prosthetics (“O&P”) space and we are excited about future partnerships in Mable Health.”

Mable Health acquired Médicus from Metro Inc. and the Bleau Family. In addition to SeaFort Capital Fund II LP, Michel Coutu, Jacinte Bleau, and Michel Lanctôt are now shareholders in Mable Health with Médicus existing as a wholly-owned subsidiary. Michel Coutu will serve as Board Chair for Mable Health. Mr. Coutu previously served as the President and CEO of The Jean Coutu Group USA, was a member of the Board of Directors of the National Association of Chain Drug Stores in the United States, and was Co-Chair of the Board of Directors of Rite Aid Corporation.

Advertisement

Mable Health will continue to focus on building a national platform, expanding across Canada through strategic acquisitions, partnerships, and greenfield expansion.

Advertisement

Stories continue below